Recombinant DNA Technology Market Size, Share & Trends Report

Recombinant DNA Technology Market Size, Share & Trends Analysis Report By Product (Therapeutic Agent, Vaccine, Biotech Crops, Specialty Chemicals), By Component, By Application, By End-use, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-872-5
  • Number of Pages: 210
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • Product Outlook (Revenue, USD Billion, 2014 - 2025)
    • Medical
      • Therapeutic Agent
      • Human Protein
      • Vaccine
    • Non-medical
      • Biotech Crops
      • Specialty Chemicals
      • Others
  • Component Type Outlook (Revenue, USD Billion, 2014 - 2025)
    • Expression System
      • Mammalian
      • Bacteria
      • Yeast
      • Baculovirus/insect
      • Others
    • Cloning Vector
  • Application Outlook (Revenue, USD Billion, 2014 - 2025)
    • Food & Agriculture
    • Health & Disease
      • Human
      • Animal
    • Environment
    • Others
  • End-use Outlook (Revenue, USD Billion, 2014 - 2025)
    • Biotechnology and Pharmaceutical Companies
    • Biotechnology and Pharmaceutical Companies
    • Others
  • Regional Outlook (Revenue, USD Billion, 2014 - 2025)
    • North America
      • North America Recombinant DNA Technology Market, By product
        • Medical
          • Therapeutic Agent
          • Human Protein
          • Vaccine
        • Non-medical
          • Biotech Crops
          • Specialty Chemicals
          • Others
      • North America Recombinant DNA Technology Market, By Component
        • Expression System
          • Mammalian
          • Bacteria
          • Yeast
          • Baculovirus/insect
          • Others
        • Cloning Vector
      • North America Recombinant DNA Technology Market, By Application
        • Food & Agriculture
        • Health & Disease
          • Human
          • Animal
        • Environment
        • Others
      • North America Recombinant DNA Technology Market, By End-use
        • Biotechnology and Pharmaceutical Companies
        • Academic & Government Research Institutes
        • Others
      • The U.S.
        • The U.S. Recombinant DNA Technology Market, By Product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • The U.S. Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • The U.S. Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • The U.S. Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others
      • Canada
        • Canada Recombinant DNA Technology Market, By Product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • Canada Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • Canada Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • Canada Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others
    • Europe
      • Europe Recombinant DNA Technology Market, By product
        • Medical
          • Therapeutic Agent
          • Human Protein
          • Vaccine
        • Non-medical
          • Biotech Crops
          • Specialty Chemicals
          • Others
      • Europe Recombinant DNA Technology Market, By Component
        • Expression System
          • Mammalian
          • Bacteria
          • Yeast
          • Baculovirus/insect
          • Others
        • Cloning Vector
      • Europe Recombinant DNA Technology Market, By Application
        • Food & Agriculture
        • Health & Disease
          • Human
          • Animal
        • Environment
        • Others
      • Europe Recombinant DNA Technology Market, By End-use
        • Biotechnology and Pharmaceutical Companies
        • Academic & Government Research Institutes
        • Others
      • Germany
        • Germany Recombinant DNA Technology Market, By Product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • Germany Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • Germany Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • Germany Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others
      • The U.K.
        • The U.K. Recombinant DNA Technology Market, By Product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • The U.K. Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • The U.K. Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • The U.K. Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others
    • Asia Pacific
      • Asia Pacific Recombinant DNA Technology Market, By product
        • Medical
          • Therapeutic Agent
          • Human Protein
          • Vaccine
        • Non-medical
          • Biotech Crops
          • Specialty Chemicals
          • Others
      • Asia Pacific Recombinant DNA Technology Market, By Component
        • Expression System
          • Mammalian
          • Bacteria
          • Yeast
          • Baculovirus/insect
          • Others
        • Cloning Vector
      • Asia Pacific Recombinant DNA Technology Market, By Application
        • Food & Agriculture
        • Health & Disease
          • Human
          • Animal
        • Environment
        • Others
      • Asia Pacific Recombinant DNA Technology Market, By End-use
        • Biotechnology and Pharmaceutical Companies
        • Academic & Government Research Institutes
        • Others
      • China
        • China Recombinant DNA Technology Market, By Product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • China Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • China Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • China Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others
      • Japan
        • Japan Recombinant DNA Technology Market, By Product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • Japan Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • Japan Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • Japan Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others
    • Latin America
        • Latin America Recombinant DNA Technology Market, By product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • Latin America Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • Latin America Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • Latin America Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others
        • Brazil
          • Brazil Recombinant DNA Technology Market, By Product
            • Medical
              • Therapeutic Agent
              • Human Protein
              • Vaccine
            • Non-medical
              • Biotech Crops
              • Specialty Chemicals
              • Others
          • Brazil Recombinant DNA Technology Market, By Component
            • Expression System
              • Mammalian
              • Bacteria
              • Yeast
              • Baculovirus/insect
              • Others
            • Cloning Vector
          • Brazil Recombinant DNA Technology Market, By Application
            • Food & Agriculture
            • Health & Disease
              • Human
              • Animal
            • Environment
            • Others
          • Brazil Recombinant DNA Technology Market, By End-use
            • Biotechnology and Pharmaceutical Companies
            • Academic & Government Research Institutes
            • Others
    • The Middle East & Africa (MEA)
      • MEA Recombinant DNA Technology Market, By product
        • Medical
          • Therapeutic Agent
          • Human Protein
          • Vaccine
        • Non-medical
          • Biotech Crops
          • Specialty Chemicals
          • Others
      • MEA Recombinant DNA Technology Market, By Component
        • Expression System
          • Mammalian
          • Bacteria
          • Yeast
          • Baculovirus/insect
          • Others
        • Cloning Vector
      • MEA Recombinant DNA Technology Market, By Application
        • Food & Agriculture
        • Health & Disease
          • Human
          • Animal
        • Environment
        • Others
      • MEA Recombinant DNA Technology Market, By End-use
        • Biotechnology and Pharmaceutical Companies
        • Academic & Government Research Institutes
        • Others
      • South Africa
        • South Africa Recombinant DNA Technology Market, By Product
          • Medical
            • Therapeutic Agent
            • Human Protein
            • Vaccine
          • Non-medical
            • Biotech Crops
            • Specialty Chemicals
            • Others
        • South Africa Recombinant DNA Technology Market, By Component
          • Expression System
            • Mammalian
            • Bacteria
            • Yeast
            • Baculovirus/insect
            • Others
          • Cloning Vector
        • South Africa Recombinant DNA Technology Market, By Application
          • Food & Agriculture
          • Health & Disease
            • Human
            • Animal
          • Environment
          • Others
        • South Africa Recombinant DNA Technology Market, By End-use
          • Biotechnology and Pharmaceutical Companies
          • Academic & Government Research Institutes
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon